Holen Sie sich die Stockscreener-App
4.35
50.34%
-4.41
Handel nachbörslich:
4.55
0.20
+4.60%
Schlusskurs vom Vortag:
$8.76
Offen:
$4.4
24-Stunden-Volumen:
597.86K
Relative Volume:
0.93
Marktkapitalisierung:
$3.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.60M
KGV:
-1.3766
EPS:
-3.16
Netto-Cashflow:
$-8.96M
1W Leistung:
-51.88%
1M Leistung:
-56.19%
6M Leistung:
-29.95%
1J Leistung:
-41.06%
1-Tages-Spanne:
$4.20
$4.66
1-Wochen-Bereich:
$4.20
$9.38
52-Wochen-Spanne:
$4.20
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Firmenname
Artelo Biosciences Inc
Sektor
Branche
Telefon
858-925-7049
Adresse
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Vergleichen Sie ARTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
4.35 | 11.96M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-08 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Eingeleitet | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
Artelo Biosciences Prices $3 Mln Public Offering Of Common Stock And Warrants - Nasdaq
Nasdaq Gains Over 100 Points; Science Applications Shares Fall After Q2 Results - Benzinga
Artelo Biosciences Plummets 51%: A Tale of Triumph and Turmoil in Biotech's High-Stakes Arena - AInvest
Artelo Biosciences announces pricing of $3.0 million public offering - MarketScreener
Can Artelo Biosciences Inc. sustain its profitabilityCPI Data & Community Driven Trade Alerts - khodrobank.com
Artelo Biosciences prices $3 million public offering of common stock - Investing.com
Artelo Biosciences Plunges 28.08% on Public Offering Announcement - AInvest
Artelo Biosciences Announces $3M Public Offering of Common Stock and Warrants. - AInvest
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering - GlobeNewswire
$3 Million Capital Raise: Clinical-Stage Biotech Artelo Prices Public Offering for Cancer & Pain Research - Stock Titan
Form 424B5 ARTELO BIOSCIENCES, INC. - StreetInsider
Artelo Biosciences Launches Public Offering with Undetermined Size and Terms - AInvest
Artelo Biosciences Plunges 14.38% on Public Offering Announcement - AInvest
Artelo Biosciences launches public offering of common stock By Investing.com - Investing.com Canada
What Fibonacci levels say about Artelo Biosciences Inc. reboundTrade Entry Report & Safe Capital Growth Plans - Newser
Sentiment analysis tools applied to Artelo Biosciences Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
How to interpret RSI for Artelo Biosciences Inc. stockWeekly Profit Report & Safe Entry Point Identification - Newser
Artelo Biosciences reports interim Phase 2 data for cancer cachexia treatment By Investing.com - Investing.com South Africa
Is a relief rally coming for Artelo Biosciences Inc. holdersMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Will Artelo Biosciences Inc. benefit from macro trendsMarket Performance Summary & Technical Confirmation Trade Alerts - Newser
Does Artelo Biosciences Inc. offer margin of safetyJuly 2025 Momentum & Consistent Return Strategy Ideas - khodrobank.com
Artelo Biosciences announces proposed underwritten public offering - MarketScreener
Artelo Biosciences launches public offering of common stock - Investing.com
Artelo Biosciences reports interim Phase 2 data for cancer cachexia treatment - Investing.com
Artelo Biosciences launches public offering; shares down 10% - MSN
Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire
Artelo Biosciences Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants - AInvest
Clinical-Stage Pharma Artelo Biosciences Launches New Public Stock Offering via R.F. Lafferty - Stock Titan
Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal - Benzinga
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results - The Manila Times
Cancer Wasting Treatment Breakthrough: Artelo's ART27.13 Shows Promise in Phase 2 Trial for 80% of Cancer Patients - Stock Titan
Artelo Biosciences Reports Encouraging Interim Results for ART27.13 in Phase 2 Cancer Appetite Recovery Study, Supporting Weight Gain and Activity Improvements in Cancer Patients - Quiver Quantitative
Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS) - The Manila Times
Artelo Biosciences Announces Positive Interim Phase 2 CAReS - GlobeNewswire
18.5% Maximum Weight Gain: Artelo's Cancer Cachexia Drug Shows Breakthrough Results in Phase 2 Trial - Stock Titan
How to manage a losing position in Artelo Biosciences Inc.2025 Earnings Impact & Fast Moving Trade Plans - Newser
Price action breakdown for Artelo Biosciences Inc.Buy Signal & Momentum Based Trading Signals - Newser
Will Artelo Biosciences Inc. continue its uptrend2025 Top Decliners & AI Forecasted Entry and Exit Points - Newser
Quantitative breakdown of Artelo Biosciences Inc. recent move2025 Market Sentiment & Expert Verified Movement Alerts - Newser
Can Artelo Biosciences Inc. rally from current levelsTrade Risk Report & Fast Exit/Entry Strategy Plans - Newser
Can Artelo Biosciences Inc. continue delivering strong returns2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - khodrobank.com
Published on: 2025-09-02 13:42:59 - Newser
Artelo Biosciences stock triggers KDJ Golden Cross, bullish Marubozu formation. - AInvest
What’s the fair value of Artelo Biosciences Inc. stock2025 Geopolitical Influence & Technical Entry and Exit Tips - khodrobank.com
Leading vs lagging indicators on Artelo Biosciences Inc. performanceBond Market & Reliable Price Breakout Signals - Newser
Is Artelo Biosciences Inc. being accumulated by smart money2025 Market WrapUp & Risk Controlled Swing Alerts - khodrobank.com
Best data tools to analyze Artelo Biosciences Inc. stockAnalyst Upgrade & Weekly High Conviction Ideas - Newser
Custom strategy builders for tracking Artelo Biosciences Inc.Portfolio Risk Summary & Long-Term Safe Investment Plans - Newser
Institutional scanner results for Artelo Biosciences Inc.2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Tools to assess Artelo Biosciences Inc.’s risk profileBuy Signal & Growth Oriented Trade Recommendations - Newser
Artelo Biosciences Inc. stock trend outlook and recovery pathWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):